0000950170-24-058878.txt : 20240513
0000950170-24-058878.hdr.sgml : 20240513
20240513180734
ACCESSION NUMBER: 0000950170-24-058878
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240510
FILED AS OF DATE: 20240513
DATE AS OF CHANGE: 20240513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Treace John T.
CENTRAL INDEX KEY: 0001856380
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40355
FILM NUMBER: 24940691
MAIL ADDRESS:
STREET 1: C/O TREACE MEDICAL CONCEPTS, INC.
STREET 2: 203 FORT WADE ROAD, SUITE 150
CITY: PONTE VEDRA
STATE: FL
ZIP: 32081
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TREACE MEDICAL CONCEPTS, INC.
CENTRAL INDEX KEY: 0001630627
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 471052611
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 PALMETTO PARK PLACE
CITY: PONTE VEDRA
STATE: FL
ZIP: 32081
BUSINESS PHONE: (904) 373-5940
MAIL ADDRESS:
STREET 1: 100 PALMETTO PARK PLACE
CITY: PONTE VEDRA
STATE: FL
ZIP: 32081
4
1
ownership.xml
4
X0508
4
2024-05-10
0001630627
TREACE MEDICAL CONCEPTS, INC.
TMCI
0001856380
Treace John T.
C/O TREACE MEDICAL CONCEPTS, INC.
100 PALMETTO PARK PLACE
PONTE VEDRA
FL
32081
true
true
true
false
Chief Executive Officer
false
Common Stock
2024-05-10
4
P
false
150000
4.5792
A
5943095
D
Common Stock
2024-05-13
4
P
false
150000
4.5566
A
6093095
D
Common Stock
1605000
I
By spouse
Common Stock
1471250
I
By spouse as co-trustee of a trust
Common Stock
1839063
I
as trustee of a trust
Common Stock
408816
I
as co-trustee of a trust
The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.4700 to $4.7500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
Includes 196,646 restricted stock units
The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3900 to $4.6400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.
/s/ Lisa O. Taylor as Attorney in Fact for John T. Treace
2024-05-13